Literature DB >> 1981889

Phenotypic characterization of macrophage subpopulations and localization of factor XIII in the stromal cells of carcinomas.

K Turnock1, J N Bulmer, C Gray.   

Abstract

The infiltration of macrophages both within and at the margin of malignant neoplasms can be extensive, but their functions are not well defined. Definitions of the antigenic phenotype defined by various monoclonal antibodies may allow insight into macrophage function. Single and double immunoenzymatic labelling techniques were used to characterize sub-populations of macrophages both within and at the margin of breast carcinoma and colorectal carcinoma using a panel of antibodies. Factor XIII, previously identified in macrophage cytoplasm, was localized at the same sites. Two major groups of tumour-associated macrophages were identified; class II MHC+, CD11c+ macrophages predominated within the neoplasm, whereas CD14+ macrophages were the major population at the invasive margin. Factor XIII+ macrophages were also seen predominantly at the invasive margin. Phenotypic variation between macrophage sub-populations may reflect functional variation such that macrophages may be beneficial or detrimental for neoplastic growth. Factor XIII derived from macrophages may be important in stabilization of fibrin deposits associated with the neoplasm.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981889     DOI: 10.1007/bf01047450

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  12 in total

1.  Cytological observations on carcinoma.

Authors:  R A O'MEARA; R D JACKSON
Journal:  Ir J Med Sci       Date:  1958-07       Impact factor: 1.568

2.  The p150,95 molecule is a marker of human mononuclear phagocytes: comparison with expression of class II molecules.

Authors:  N Hogg; L Takacs; D G Palmer; Y Selvendran; C Allen
Journal:  Eur J Immunol       Date:  1986-03       Impact factor: 5.532

3.  Discrimination of human macrophages and dendritic cells by means of monoclonal antibodies.

Authors:  L W Poulter; D A Campbell; C Munro; G Janossy
Journal:  Scand J Immunol       Date:  1986-09       Impact factor: 3.487

Review 4.  Phenotype and functions of intratumoral macrophages.

Authors:  W H McBride
Journal:  Biochim Biophys Acta       Date:  1986-08-05

5.  Identification of blood coagulation factor XIII in human peritoneal macrophages.

Authors:  R Adány; A Belkin; T Vasilevskaya; L Muszbek
Journal:  Eur J Cell Biol       Date:  1985-07       Impact factor: 4.492

6.  Factor XIII of blood coagulation in human monocytes.

Authors:  L Muszbek; R Adány; G Szegedi; J Polgár; M Kávai
Journal:  Thromb Res       Date:  1985-02-01       Impact factor: 3.944

7.  Identification of intracellular factor XIII in human monocytes and macrophages.

Authors:  P Henriksson; S Becker; G Lynch; J McDonagh
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

8.  [Hepatic fibrosis and coagulation factor XIII].

Authors:  S Iwabuchi
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1983-10

9.  Cross-linking of collagen and fibronectin by factor XIIIa. Localization of participating glutaminyl residues to a tryptic fragment of fibronectin.

Authors:  D F Mosher; P E Schad; J M Vann
Journal:  J Biol Chem       Date:  1980-02-10       Impact factor: 5.157

10.  Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and infarction.

Authors:  H F Dvorak; G R Dickersin; A M Dvorak; E J Manseau; K Pyne
Journal:  J Natl Cancer Inst       Date:  1981-08       Impact factor: 13.506

View more
  2 in total

1.  Immunological characterization and activity of transglutaminases in human normal and malignant prostate and in prostate cancer cell lines.

Authors:  B Friedrichs; H Riedmiller; H W Goebel; U Rausch; G Aumüller
Journal:  Urol Res       Date:  1995

Review 2.  Factor XIII Subunit A in the Skin: Applications in Diagnosis and Treatment.

Authors:  Lilla Paragh; Daniel Törőcsik
Journal:  Biomed Res Int       Date:  2017-08-15       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.